Literature DB >> 17404005

Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.

Andrea Endimiani1, Francesco Luzzaro, Roberta Migliavacca, Elisabetta Mantengoli, Andrea M Hujer, Kristine M Hujer, Laura Pagani, Robert A Bonomo, Gian Maria Rossolini, Antonio Toniolo.   

Abstract

Clinical isolates of Acinetobacter baumannii (n = 470) were collected during a 7-year period and investigated for the genetic determinants of resistance to expanded-spectrum beta-lactams. Thirty-one isolates produced the TEM-92 extended-spectrum beta-lactamase (ESBL) and were clonally related. This is the first report of A. baumannii producing a TEM-type ESBL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404005      PMCID: PMC1891385          DOI: 10.1128/AAC.01139-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France.

Authors:  L Poirel; A Karim; A Mercat; I Le Thomas; H Vahaboglu; C Richard; P Nordmann
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

2.  New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.

Authors:  C de Champs; C Monne; R Bonnet; W Sougakoff; D Sirot; C Chanal; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea.

Authors:  Dongeun Yong; Jong Hee Shin; Sinyoung Kim; Youngsik Lim; Jong Hwa Yum; Kyungwon Lee; Yunsop Chong; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  [Study on the molecular epidemiology of SHV type beta-lactamase-encoding genes of multiple-drug-resistant acinetobacter baumannii].

Authors:  Zhi-mi Huang; Pei-hua Mao; Yu Chen; Lei Wu; Jing Wu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2004-05

6.  Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.

Authors:  H Vahaboglu; R Oztürk; G Aygün; F Coşkunkan; A Yaman; A Kaygusuz; H Leblebicioglu; I Balik; K Aydin; M Otkun
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  F Luzzaro; M Perilli; G Amicosante; G Lombardi; R Belloni; A Zollo; C Bianchi; A Toniolo
Journal:  Int J Antimicrob Agents       Date:  2001-02       Impact factor: 5.283

Review 8.  Antimicrobial resistance of Acinetobacter spp. in Europe.

Authors:  M Van Looveren; H Goossens
Journal:  Clin Microbiol Infect       Date:  2004-08       Impact factor: 8.067

9.  Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy.

Authors:  Laura Pagani; Emanuela Dell'Amico; Roberta Migliavacca; Marco Maria D'Andrea; Ernesto Giacobone; Gianfranco Amicosante; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital.

Authors:  Laurent Poirel; Olivier Menuteau; Nathalie Agoli; Christian Cattoen; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  11 in total

1.  Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.

Authors:  Heba Shehta Said; Abdalbagi Basheer Benmahmod; Ramadan Hassan Ibrahim
Journal:  World J Microbiol Biotechnol       Date:  2018-12-03       Impact factor: 3.312

2.  Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates.

Authors:  Andrea Endimiani; Andrea M Hujer; Kristine M Hujer; Julian A Gatta; Andrew C Schriver; Michael R Jacobs; Louis B Rice; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti.

Authors:  Anaïs Potron; L Silvia Munoz-Price; Patrice Nordmann; Timothy Cleary; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

5.  PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.

Authors:  Tatsuya Tada; Shovita Shrestha; Kayo Shimada; Hiroshi Ohara; Jeevan B Sherchand; Bharat M Pokhrel; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

6.  PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii.

Authors:  Rémy A Bonnin; Anaïs Potron; Laurent Poirel; Hervé Lecuyer; Rita Neri; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

Review 7.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

Review 10.  Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.

Authors:  Mariana Castanheira; Patricia J Simner; Patricia A Bradford
Journal:  JAC Antimicrob Resist       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.